Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Net Cash Flow (2016 - 2025)

Utah Medical Products has reported Net Cash Flow over the past 16 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $1.4 million for Q4 2025, up 128.99% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (up 121.52% YoY), and the annual figure for FY2025 was $2.0 million, up 121.52%.
  • Net Cash Flow for Q4 2025 was $1.4 million at Utah Medical Products, down from $2.2 million in the prior quarter.
  • Over the last five years, Net Cash Flow for UTMD hit a ceiling of $5.8 million in Q1 2023 and a floor of -$4.8 million in Q4 2024.
  • Median Net Cash Flow over the past 5 years was $2.8 million (2021), compared with a mean of $1.7 million.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 307.91% in 2021 and later tumbled 226.79% in 2024.
  • Utah Medical Products' Net Cash Flow stood at -$3.3 million in 2021, then skyrocketed by 241.55% to $4.7 million in 2022, then dropped by 11.67% to $4.2 million in 2023, then crashed by 215.54% to -$4.8 million in 2024, then skyrocketed by 128.99% to $1.4 million in 2025.
  • The last three reported values for Net Cash Flow were $1.4 million (Q4 2025), $2.2 million (Q3 2025), and -$1.7 million (Q2 2025) per Business Quant data.